Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.7951
-0.0357 (-4.30%)
Sep 9, 2026, 1:53 PM EDT - Market open
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $818.21 thousand as of September 9, 2026. Its market cap has decreased by -75.17% in one year.
Market Cap
818.21K
Enterprise Value
-10.59M
1-Year Change
-75.17%
Ranking
Category
Stock Price
$0.80
ChartMarket Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $818.21K, a decrease of -99.20%. That is a compound annual growth rate of -47.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 818.21K | -57.03% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.33M |
| Propanc Biopharma | 2.30M |
| Valion Bio | 2.26M |
| Jaguar Health | 2.25M |
| Virax Biolabs Group | 2.07M |
| Silexion Therapeutics | 1.95M |
| Decoy Therapeutics | 1.82M |
| Endovia Health Sciences | 1.71M |